Provided by Tiger Trade Technology Pte. Ltd.

Assembly Biosciences

35.00
+0.62001.80%
Volume:91.88K
Turnover:3.20M
Market Cap:712.62M
PE:-13.63K
High:35.48
Open:34.38
Low:33.75
Close:34.38
52wk High:39.71
52wk Low:20.23
Shares:20.36M
Float Shares:9.17M
Volume Ratio:1.06
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0026
EPS(LYR):-0.5461
ROE:-0.03%
ROA:-2.67%
PB:2.33
PE(LYR):-64.09

Loading ...

Assembly Biosciences Price Target Maintained with a $50.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 18

Assembly Biosciences: Strategic Pipeline Expansion, Strong Cash Position Support Unchanged $50 Price Target and Buy Rating

TIPRANKS
·
Aug 18

Assembly Climbs on Quarterly Revenue Beat

Reuters
·
Aug 14

Assembly Bio Releases Corporate Deck Highlighting Clinical-Stage Pipeline, Gilead-Partnered HSV Program

Reuters
·
Aug 14

Assembly Biosciences Q2 Net Loss Narrows as Revenue Rises

Reuters
·
Aug 14

Assembly Biosciences Q2 EPS $(0.20) Beats $(0.65) Estimate, Sales $13.374M Beat $8.599M Estimate

Benzinga Earnings
·
Aug 14

Assembly Biosciences Q2 Income from Operations USD -6.344 Million

THOMSON REUTERS
·
Aug 14

Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates

GlobeNewswire
·
Aug 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 11

Assembly Biosciences Is Maintained at Outperform by Mizuho

Dow Jones
·
Jun 16

Assembly Biosciences Inc : Mizuho Raises Target Price to $45 From $40

THOMSON REUTERS
·
Jun 15

U.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology

Reuters
·
Jun 15

Mizuho Securities Keeps Their Buy Rating on Assembly Biosciences (ASMB)

TIPRANKS
·
Jun 13

Assembly Biosciences Expands Equity Plans, Reelects Board

TIPRANKS
·
Jun 06

H.C. Wainwright Reaffirms Their Buy Rating on Assembly Biosciences (ASMB)

TIPRANKS
·
Jun 04

Assembly Biosciences Announces Upcoming Investor Conference Presentations

GlobeNewswire
·
May 29

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Apogee Therapeutics (APGE) and Align Tech (ALGN)

TIPRANKS
·
May 28

Assembly Biosciences Price Target Maintained With a $43.00/Share by Guggenheim

Dow Jones
·
May 28

Guggenheim Sticks to Their Buy Rating for Assembly Biosciences (ASMB)

TIPRANKS
·
May 28

Assembly Bio publishes corporate presentation on clinical-stage antiviral and liver disease pipeline, Gilead partnership

Reuters
·
May 27